Management of Diabetic Foot Infections Using Phage Products: Unveiling TP-102 Phase IIb Study

Time: 11:30 am
day: Day One


  • Articulating regulatory challenges in phage development to enable treatment of human disease 
  • Showcasing design of clinical trial protocol for safe and effective Phase IIb phage product 
  • Highlighting critical findings of phage therapy to treat diabetic foot infections from preliminary results